Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.075
Sell
RSI(14)
28.206
Sell
STOCH(KDJ)(9,3,3)
23.969
Buy
ATR(14)
0.138
High Vlolatility
CCI(14)
-54.036
Neutral
Williams %R
91.000
Oversold
TRIX(12,20)
-2.015
Sell
StochRSI(14)
90.121
Buy
Search
Dare Bioscience Inc
DAREAdd to Watchlist
1.220USD
-0.020-1.61%
Close 07-31 16:00（ET）Quotes delayed by 15 min
16.99MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-1.61%
5 Days
-4.69%
1 Month
-42.18%
6 Months
-32.60%
Year to Date
-36.79%
1 Year
-49.17%
Key Figures
1.240Open
1.270High
73.27KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.53%Turnover Ratio
1.240Prev. Close
1.210Low
74.31KTurnover
LossP/E Static
5.95P/B
0.00%Div Yield TTM
-51.76%ROA
9.19052wk High
0.48Volume Ratio
-4.05MNet Profit
13.93MShares
-0.9053EPS TTM
1.08Beta
-2543.13%ROE
1.27052wk Low
4.85%Amplitude
-58.95%Gross Margin
16.99MMarket Cap
-7.49Reward/Risk
5.43%Risk Rate
TradingKey Stock Score of Dare Bioscience Inc
Currency: USD Updated: 2026-07-31Key Insights
Dare Bioscience Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 71 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 10.25.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Dare Bioscience Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Dare Bioscience Inc Highlights
StrengthsRisks
Dare Bioscience, Inc. is a biopharmaceutical company. The Company's programs target unmet needs in women's health, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Its product includes XACIATO (clindamycin phosphate) vaginal gel 2%. XACIATO is a single-dose prescription medication for the treatment of bacterial vaginosis in females 12 years of age and older. Its other product candidates include Ovaprene, Sildenafil Cream, and DARE-HRT1. Ovaprene is an investigational, hormone-free, monthly intravaginal contraceptive. Sildenafil Cream is a novel cream formulation of sildenafil for the treatment of female sexual arousal disorder; and DARE-HRT1 is an intravaginal ring designed to deliver a combination of menopausal hormone therapy, bio-identical 17b-estradiol and progesterone together, continuously over a 28-day period for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.03M.
Fairly Valued
The company’s latest PE is -1.35, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.25M shares, increasing 13.30% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 7.96K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.59.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
10.250
Target Price
+783.62%
Upside Space
Dare Bioscience Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
3
analysts
Buy
Current Rating
10.250
Target Price
+783.62%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Dare Bioscience Inc
DARE
3
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Indicators
Moving Average
Indicators
Value
Direction
MA5
1.225
Sell
MA10
1.248
Sell
MA20
1.643
Sell
MA50
1.929
Sell
MA100
1.994
Sell
MA200
1.940
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Dare Bioscience Inc Info
Dare Bioscience, Inc. is a biopharmaceutical company. The Company's programs target unmet needs in women's health, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Its product includes XACIATO (clindamycin phosphate) vaginal gel 2%. XACIATO is a single-dose prescription medication for the treatment of bacterial vaginosis in females 12 years of age and older. Its other product candidates include Ovaprene, Sildenafil Cream, and DARE-HRT1. Ovaprene is an investigational, hormone-free, monthly intravaginal contraceptive. Sildenafil Cream is a novel cream formulation of sildenafil for the treatment of female sexual arousal disorder; and DARE-HRT1 is an intravaginal ring designed to deliver a combination of menopausal hormone therapy, bio-identical 17b-estradiol and progesterone together, continuously over a 28-day period for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes.
Ticker SymbolDARE
CompanyDare Bioscience Inc
CEOJohnson (Sabrina Martucci)
Websitehttps://www.darebioscience.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-0.92%
-2.51%
+0.32%
-1.45%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
+1.30%
-0.90%
-2.15%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Dare Bioscience Inc (DARE)?
The current price of Dare Bioscience Inc (DARE) is 1.23.
What is the symbol of Dare Bioscience Inc?
The ticker symbol of Dare Bioscience Inc is DARE.
What is the 52-week high of Dare Bioscience Inc?
The 52-week high of Dare Bioscience Inc is 9.19.
What is the 52-week low of Dare Bioscience Inc?
The 52-week low of Dare Bioscience Inc is 1.27.
What is the market capitalization of Dare Bioscience Inc?
The market capitalization of Dare Bioscience Inc is 17.13M.
Is Dare Bioscience Inc (DARE) currently rated as Buy, Hold, or Sell?
According to analysts, Dare Bioscience Inc (DARE) has an overall rating of Buy, with a price target of 10.25.
What is the Earnings Per Share (EPS TTM) of Dare Bioscience Inc (DARE)?
The Earnings Per Share (EPS TTM) of Dare Bioscience Inc (DARE) is -1.20.